Prevention of stroke: a global perspective
Along with the rising global burden of disability attributed to stroke, costs of stroke care are
rising, providing the impetus to direct our research focus towards effective measures of …
rising, providing the impetus to direct our research focus towards effective measures of …
The burden of cardiovascular disease in low-and middle-income countries: epidemiology and management
ADK Bowry, J Lewey, SB Dugani… - Canadian Journal of …, 2015 - Elsevier
Cardiovascular disease (CVD) is the second leading cause of mortality worldwide,
accounting for 17 million deaths in 2013. More than 80% of these cases were in low-and …
accounting for 17 million deaths in 2013. More than 80% of these cases were in low-and …
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
Background A fixed-dose combination therapy (polypill strategy) has been proposed as an
approach to reduce the burden of cardiovascular disease, especially in low-income and …
approach to reduce the burden of cardiovascular disease, especially in low-income and …
Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications
Background Older people taking multiple medications represent a large and growing
proportion of the population. Managing multiple medications can be challenging, and this is …
proportion of the population. Managing multiple medications can be challenging, and this is …
The PERSIAN cohort: providing the evidence needed for healthcare reform
S Eghtesad, Z Mohammadi, A Shayanrad… - Archives of Iranian …, 2017 - journalaim.com
In the past, communicable diseases caused the highest mortality in Iran. Improvements in
socioeconomic status and living standards including access to safe drinking water, along …
socioeconomic status and living standards including access to safe drinking water, along …
Chronic disease research in Europe and the need for integrated population cohorts
The burden of chronic disease in Europe is characterized by several positive trends, but also
some major new challenges. On one hand there has been an important and consistent …
some major new challenges. On one hand there has been an important and consistent …
Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
E Bahiru, AN De Cates, MRB Farr… - Cochrane Database …, 2017 - cochranelibrary.com
Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death
and disability worldwide, yet ASCVD risk factor control and secondary prevention rates …
and disability worldwide, yet ASCVD risk factor control and secondary prevention rates …
Uses of polypills for cardiovascular disease and evidence to date
Polypills have been approved in more than 30 countries, but worldwide experience with and
availability of polypills remain limited, unlike fixed-dose combinations in other diseases such …
availability of polypills remain limited, unlike fixed-dose combinations in other diseases such …
Strengths and limitations of using the polypill in cardiovascular prevention
A Roy, N Naik, K Srinath Reddy - Current cardiology reports, 2017 - Springer
Abstract Purpose of Review Polypill and its role in cardiovascular disease (CVD) prevention
has been extensively discussed and debated since the inception of the concept in 2003 …
has been extensively discussed and debated since the inception of the concept in 2003 …
Fixed-dose combination (polypill) for cardiovascular disease prevention: a meta-analysis
Introduction This meta-analysis was performed to assess the efficacy of fixed-dose
combination (polypill) in reducing the risk of mortality and cardiovascular events. Methods …
combination (polypill) in reducing the risk of mortality and cardiovascular events. Methods …